These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17464459)

  • 1. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
    Kusakabe A; Tanaka Y; Orito E; Sugauchi F; Kurbanov F; Sakamoto T; Shinkai N; Hirashima N; Hasegawa I; Ohno T; Ueda R; Mizokami M
    J Gastroenterol; 2007 Apr; 42(4):298-305. PubMed ID: 17464459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
    Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
    Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
    Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic mutations with amino acid substitutions of circulating hepatitis B virus found in non-B, non-C patients with hepatocellular carcinoma.
    Nakamoto N; Saito H; Ebinuma H; Tada S; Saito Y; Kurita S; Kitamura K; Ishii H
    Intern Med; 2003 Apr; 42(4):322-30. PubMed ID: 12729320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
    J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
    Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
    Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
    Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
    Chen CH; Changchien CS; Lee CM; Tung WC; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    Int J Cancer; 2009 Aug; 125(3):621-9. PubMed ID: 19431214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
    Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
    Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
    World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
    Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
    Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
    Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.